IBS and colitis are not the same condition. They can produce overlapping symptoms like abdominal pain and diarrhea, which is why people confuse them, but they differ in a fundamental way: colitis involves visible inflammation and damage to the colon lining, while IBS does not. This distinction changes everything about how each condition is diagnosed, treated, and monitored over time.
The Core Difference: Inflammation vs. Sensitivity
Colitis, most commonly ulcerative colitis, is an inflammatory bowel disease (IBD). During a colonoscopy, doctors can see clear signs of damage: swollen tissue, redness, loss of the normal blood vessel pattern, and in more severe cases, ulcers and spontaneous bleeding. Even when a person with ulcerative colitis feels fine, their immune system is often still active at a low level, with elevated inflammatory markers in the gut lining.
IBS is a functional disorder. If you looked at the intestinal lining of someone with IBS under a microscope, it would typically appear normal. The problem isn’t structural damage. Instead, it’s a heightened sensitivity in the gut-brain connection. The nerves in the digestive tract overreact to normal stimuli like gas, food moving through the intestines, or stress. This visceral hypersensitivity explains why people with IBS can have severe symptoms without any detectable inflammation, and why centrally acting medications that target the nervous system often help.
How Symptoms Overlap and Diverge
Both conditions cause abdominal pain, cramping, bloating, and changes in bowel habits. That’s where the similarity largely ends. IBS can swing between constipation and diarrhea, or present as one or the other. Abdominal pain is the defining feature. Without it, an IBS diagnosis doesn’t hold up under current diagnostic criteria.
Colitis, on the other hand, produces symptoms that IBS does not. Bleeding from the rectum, anemia, unexplained weight loss, and fever are hallmarks of inflammatory bowel disease. If you’re experiencing any of these, that points away from IBS and toward something that needs urgent evaluation. Colitis can also cause symptoms at night that wake you from sleep, which is uncommon in IBS.
How Each Condition Is Diagnosed
IBS is diagnosed based on a pattern of symptoms. The current standard, known as the Rome IV criteria, requires recurrent abdominal pain linked to bowel movements or changes in stool frequency and appearance. These symptoms need to have started at least six months before diagnosis and been active for the most recent three months. There’s no single test that confirms IBS. Instead, doctors rule out other conditions and match the symptom pattern.
Colitis requires direct evidence of inflammation. Colonoscopy is the primary diagnostic tool. In ulcerative colitis, doctors look for continuous inflammation starting at the rectum and extending upward through the colon, with characteristic signs like tissue swelling, erosions, and a fragile mucosal surface that bleeds easily when touched.
A simple stool test can also help separate the two. Fecal calprotectin, a protein released by inflamed intestinal tissue, runs at normal or very low levels in IBS. In one study, a calprotectin level above 188 micrograms per gram distinguished ulcerative colitis from diarrhea-predominant IBS with 98.5% sensitivity and 96.6% specificity. Levels below about 40 micrograms per gram generally indicate no significant inflammation. This test can save some patients from needing a colonoscopy when IBS is the more likely explanation.
The Microscopic Colitis Problem
There’s an important caveat. Microscopic colitis is a form of colitis where the colon looks completely normal during a standard colonoscopy. The inflammation only shows up under a microscope when tissue samples are analyzed. This means it can easily be mistaken for IBS, since the symptoms (chronic watery diarrhea, abdominal discomfort) look nearly identical.
In one study of 82 patients with confirmed microscopic colitis, 28% met the symptom-based criteria for diarrhea-predominant IBS. The clinical takeaway is that symptom checklists alone aren’t specific enough to rule out microscopic colitis. Patients with persistent diarrhea-predominant symptoms may benefit from biopsies taken during colonoscopy, particularly from the right side of the colon, where microscopic colitis is most evident.
Treatment Takes Completely Different Paths
Because the underlying problems are so different, the treatments barely overlap. Colitis treatment targets the immune system. Mild to moderate cases may be managed with anti-inflammatory medications. More severe or treatment-resistant cases require immunosuppressants or biologic therapies: protein-based drugs that block specific inflammatory pathways. The goal is mucosal healing, actually resolving the visible damage in the colon lining, because ongoing inflammation raises the risk of complications over time.
IBS treatment focuses on managing symptoms and calming the overactive gut-brain signals. Depending on whether constipation or diarrhea predominates, treatment might include dietary changes, medications that adjust gut motility, or drugs that reduce visceral sensitivity. Antispasmodics can ease cramping. Antidepressants at low doses are sometimes used not for mood but because they dampen pain signaling in the gut.
Diet plays a role in both conditions but in different ways. The low-FODMAP diet, which restricts certain fermentable carbohydrates, is a well-established approach for IBS. It also shows benefits for IBD patients who have IBS-like symptoms during remission. A meta-analysis found that the low-FODMAP diet reduced abdominal pain, bloating, and flatulence in IBD patients and improved quality of life compared to control diets. Importantly, though, the diet did not change disease activity or inflammatory markers in IBD, meaning it helps with comfort but doesn’t treat the underlying colitis.
You Can Have Both
One of the more frustrating realities is that IBS and colitis can coexist. About one in three people with inflammatory bowel disease in remission still report IBS-type symptoms like pain, bloating, and erratic bowel habits, even when their inflammation is well controlled. The pooled prevalence from a meta-analysis of 27 studies was 32.5%.
This overlap matters because it changes how persistent symptoms should be interpreted. If someone with ulcerative colitis still feels terrible despite tests showing their inflammation is under control, the answer isn’t necessarily stronger immunosuppression. It may be that IBS-type gut-brain dysfunction is driving their remaining symptoms, and that calls for a different treatment strategy altogether.
How Common Each Condition Is
IBS is far more prevalent. About 5% of the global population meets the current diagnostic criteria, making it one of the most common gastrointestinal disorders. Ulcerative colitis and Crohn’s disease combined affect roughly 0.5% of Western populations. So while colitis gets more medical attention because of its severity and complications, IBS affects roughly ten times as many people.